Cellular and molecular mechanisms of liver injury

被引:480
|
作者
Malhi, Harmeet [1 ]
Gores, Gregory J. [1 ]
机构
[1] Mayo Clin, Miles & Shirley Fiterman Ctr Digest Dis, Rochester, MN 55905 USA
关键词
D O I
10.1053/j.gastro.2008.03.002
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Derangements in apoptosis of liver cells are mechanistically important in the pathogenesis of end-stage liver disease. Vulnerable hepatocytes can undergo apoptosis via an extrinsic, death receptor-mediated pathway, or alternatively intracellular stress can activate the intrinsic pathway of apoptosis. Both pathways converge on mitochondria, and mitochondrial dysfunction is a prerequisite for hepatocyte apoptosis. Persistent apoptosis is a feature of chronic liver diseases, and massive apoptosis is a feature of acute liver diseases. Fibrogenesis is stimulated by ongoing hepatocyte apoptosis, eventually resulting in cirrhosis of the liver in chronic liver diseases. Endothelial cell apoptosis occurs in ischemia-reperfusion injury. Natural killer and natural killer T cells remove virus-infected hepatocytes by death receptor-mediated fibrosis. Lastly, activated stellate cell apoptosis leads to slowing and resolution of apoptosis. This review summarizes recent cellular and molecular advances in the understanding of the injury mechanisms leading to end-stage liver disease.
引用
收藏
页码:1641 / 1654
页数:14
相关论文
共 50 条
  • [41] Cellular and molecular mechanisms underlying bone marrow and liver fibrosis: a review
    Le Bousse-Kerdiles, Marie-Caroline
    Martyre, Marie-Claire
    Samson, Michel
    EUROPEAN CYTOKINE NETWORK, 2008, 19 (02) : 69 - 80
  • [42] Cellular Mechanisms of Liver Fibrosis
    Acharya, Pragyan
    Chouhan, Komal
    Weiskirchen, Sabine
    Weiskirchen, Ralf
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [43] Cellular and Molecular Mechanisms of Kidney Injury in 2,8-Dihydroxyadenine Nephropathy
    Klinkhammer, Barbara Mara
    Djudjaj, Sonja
    Kunter, Uta
    Palsson, Runolfur
    Edvardsson, Vidar Orn
    Wiech, Thorsten
    Thorsteinsdottir, Margret
    Hardarson, Sverrir
    Foresto-Neto, Orestes
    Mulay, Shrikant R.
    Moeller, Marcus Johannes
    Jahnen-Dechent, Wilhelm
    Floege, Juergen
    Anders, Hans-Joachim
    Boor, Peter
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 31 (04): : 799 - 816
  • [44] Cellular and molecular mechanisms of sex differences in renal ischemia-reperfusion injury
    Kher, A
    Meldrum, KK
    Wang, MJ
    Tsai, BM
    Pitcher, JA
    Meldrum, DR
    CARDIOVASCULAR RESEARCH, 2005, 67 (04) : 594 - 603
  • [45] Epilepsy following cortical injury: Cellular and molecular mechanisms as targets for potential prophylaxis
    Prince, David A.
    Parada, Isabel
    Scalise, Karina
    Graber, Kevin
    Jin, Xiaoming
    Shen, Fran
    EPILEPSIA, 2009, 50 : 30 - 40
  • [46] New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis
    Fernandez, Isis E.
    Eickelberg, Oliver
    LANCET, 2012, 380 (9842): : 680 - 688
  • [47] Antitubercular drugs induced liver injury: an updated insight into molecular mechanisms
    Ezhilarasan, Devaraj
    DRUG METABOLISM REVIEWS, 2023, 55 (03) : 239 - 253
  • [48] Molecular mechanisms in liver ischemic-reperfusion injury and ischemic preconditioning
    Romanque, P
    Uribe, M
    Videla, LA
    REVISTA MEDICA DE CHILE, 2005, 133 (04) : 469 - 476
  • [50] Unraveling the Molecular and Cellular Pathogenesis of COVID-19-Associated Liver Injury
    Akkiz, Hikmet
    VIRUSES-BASEL, 2023, 15 (06):